VP (Direction of New Drug Transformation)

2025-05-08

Responsibilities:

1. Responsible for the preclinical research of the company's innovative drugs and the organization and management of phase 1 clinical trials. Including: the establishment/management/evaluation of the company's animal experimental research program in the screening stage of research projects; Establish preclinical study protocols and communicate/supervise with preclinical CRO institutions; Preparation and management of new drug application and approval data (preclinical part); Establishment of phase 1 clinical protocol and communication/supervision of clinical CRO institutions;

2. Participated in the project investigation, decision-making and project management of the company's innovative biological drug R&D; It covers tumor (T cell bispecific antibody/TCB, Antibody drug conjugates/ADC), metabolically related (diabetes, obesity, nonalcoholic fatty liver and related), and neovasculum inhibition (tumor and ophthalmology);

3. Participate in international cooperation management such as product authorization or project introduction;

4. Participated in the preparation of IND materials for biological drugs (domestic and international).


Job Requirements:

1.major in biology/pharmacology/clinical medicine or related, master degree or above;

2. Familiar with the process of preclinical and clinical trials of drugs, and the industry standards, regulations and policies of the United States Food and Drug Administration (FDA), such as the drug clinical Trial Management Practice (GCP);

3. Good English listening, speaking, reading and writing skills;

4. Have team leadership, good organization and planning skills, and good interpersonal skills; 5. More than 4 years of working experience in pharmaceutical manufacturing enterprises or preclinical or clinical CRO companies, more than 2 preclinical or clinical trial project in charge, experience in joint ventures or multinational companies is preferred, experience in metabolic/ophthalmic/oncology drug clinical trials, more than 5 years of working experience in biologic drug development, research background in pharmaceutical companies is preferred;

6. Remuneration: annual salary + project stage incentive + equity incentive.

Zhejiang Doer Biologics Co.,Ltd.

Telephone:0571-28256206

Fax:0571-28256206

Email:bd@doerbio.com

Address:Floor 2,Building 3, Hexiang Science and Technology Center, Phase 3, Medicine Port Town, Qiantang New District, Hangzhou,Zhejiang Province

© 2016-2020 Zhejiang Doer Biologics Co.,Ltd. Copyright Record number:网站备案号:浙ICP备14037239号

Scan to follow us